Back

Canadian newspapers support mifepristone medical abortion to improve fulfillment of the right to health (2015-2019)

Kendall, T.; Sriram, P.; Parmar, A.; Norman, W. V.

2022-07-12 sexual and reproductive health
10.1101/2022.07.11.22277487
Show abstract

In 2015, mifepristone, the international gold standard for medical abortion, was approved for use in Canada. Our content analysis of Canadian newspaper coverage describes arguments in favor or against medical abortion and the evolving regulatory framework for mifepristone from six months before approval until the last province included the medication as a publicly insured health benefit (2015-2019). Our study found an exceptionally high level of support for the approval, introduction and removal of regulatory barriers to mifepristone for medical abortion. Of 402 articles, 67% were pro-medical abortion, 25% presented balanced or neutral coverage and only 8% presented solely anti-medical abortion viewpoints. Of the 761 stakeholders cited, more than 90% made positive or neutral statements about medical abortion. Most articles discussed medical abortion as a health issue and contained arguments about how liberalization of the regulatory framework and public payment for mifepristone would improve abortion availability (68%), accessibility (87%), acceptability (34%) and quality (19%). Mifepristones introduction in Canada was presented in newspapers as a way to increase womens health, specifically in rural areas where disparities in abortion access exist. Rather than formal balance, which presents contrasting arguments as equally valid even when the scientific evidence for one vastly outweighs the other, our study identified evidentiary balance where coverage aligned with the majority of evidence and expert opinion. Our results differ from analyses in other high-income countries (United Kingdom, United States) that have found that media frame abortion as a stigmatized and controversial issue or mention abortion predominantly with respect to electoral politics rather than as a health issue. The Canadian print media presented overwhelmingly favorable arguments towards the expansion of mifepristone medical abortion and served to destigmatize abortion by framing the introduction and universal coverage of medical abortion as fulfilling core components of the right to health.

Matching journals

1
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 36%
13.6%
2
PLOS Global Public Health
Public Library of Science (PLoS) · based on 287 published papers
Top 4%
8.4× avg
3
Health Expectations
Wiley · based on 12 published papers
#1
118× avg
4
BMJ Open
BMJ · based on 553 published papers
Top 15%
2.0× avg
5
Sexually Transmitted Infections
BMJ · based on 20 published papers
Top 0.4%
56× avg
6
BMC Public Health
Springer Science and Business Media LLC · based on 148 published papers
Top 2%
8.2× avg
7
BMC Pregnancy and Childbirth
Springer Science and Business Media LLC · based on 19 published papers
Top 0.7%
37× avg
8
Preventive Medicine
Elsevier BV · based on 11 published papers
#1
55× avg
9
PLOS Digital Health
Public Library of Science (PLoS) · based on 88 published papers
Top 5%
5.3× avg
10
Journal of Racial and Ethnic Health Disparities
Springer Science and Business Media LLC · based on 11 published papers
Top 0.3%
44× avg
11
SSM - Population Health
Elsevier BV · based on 17 published papers
Top 0.4%
33× avg
12
Vaccines
MDPI AG · based on 131 published papers
Top 2%
7.7× avg
13
JMIR Formative Research
JMIR Publications Inc. · based on 31 published papers
Top 2%
11× avg
14
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 72%
1.6%
15
Archives of Clinical and Biomedical Research
Fortune Journals · based on 18 published papers
Top 0.9%
13× avg
16
European Journal of Human Genetics
Springer Science and Business Media LLC · based on 25 published papers
Top 2%
16× avg
17
International Journal of Epidemiology
Oxford University Press (OUP) · based on 65 published papers
Top 7%
3.6× avg
18
Journal of Medical Internet Research
JMIR Publications Inc. · based on 81 published papers
Top 12%
1.8× avg
19
npj Digital Medicine
Springer Science and Business Media LLC · based on 85 published papers
Top 13%
0.8%
20
BMC Medicine
Springer Science and Business Media LLC · based on 155 published papers
Top 21%
0.8%
21
Journal of Clinical Investigation
American Society for Clinical Investigation · based on 50 published papers
Top 5%
4.4× avg
22
BMC Infectious Diseases
Springer Science and Business Media LLC · based on 110 published papers
Top 20%
0.7%